Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial

Robert J. Motzer; Paul Russo; Naomi Haas; Christian Doehn; Frede Donskov; Marine Gross-Goupil; Sergei Varlamov; Evgeny Kopyltsov; Jae Lyun Lee; Ho Yeong Lim; Bohuslav Melichar; Milada Zemanova; Brian Rini; Toni K. Choueiri; Lori Wood; M. Neil Reaume; Arnulf Stenzl; Simon Chowdhury; Ray McDermott; Agnieszka Michael; Miguel Izquierdo; Paola Aimone; Hong Zhang; Cora N. Sternberg

doi:10.1016/j.eururo.2020.12.029

Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial

Robert J. Motzer, Paul Russo, Naomi Haas, Christian Doehn, Frede Donskov, Marine Gross-Goupil, Sergei Varlamov, Evgeny Kopyltsov, Jae Lyun Lee, Ho Yeong Lim, Bohuslav Melichar, Milada Zemanova, Brian Rini, Toni K. Choueiri, Lori Wood, M. Neil Reaume, Arnulf Stenzl, Simon Chowdhury, Ray McDermott, Agnieszka MichaelMiguel Izquierdo, Paola Aimone, Hong Zhang, Cora N. Sternberg

Research output: Contribution to journal › Article › peer-review

51 Citations (Scopus)

Original language	English
Pages (from-to)	334-338
Number of pages	5
Journal	European Urology
Volume	79
Issue number	3
DOIs	https://doi.org/10.1016/j.eururo.2020.12.029
Publication status	Published - Mar 2021
Externally published	Yes

ASJC Scopus Subject Areas

Urology

Keywords

Pazopanib
Renal cell carcinoma
Tyrosine kinase inhibitor

Access to Document

10.1016/j.eururo.2020.12.029

Cite this

Motzer, R. J., Russo, P., Haas, N., Doehn, C., Donskov, F., Gross-Goupil, M., Varlamov, S., Kopyltsov, E., Lee, J. L., Lim, H. Y., Melichar, B., Zemanova, M., Rini, B., Choueiri, T. K., Wood, L., Reaume, M. N., Stenzl, A., Chowdhury, S., McDermott, R., ... Sternberg, C. N. (2021). Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial. European Urology, 79(3), 334-338. https://doi.org/10.1016/j.eururo.2020.12.029

Motzer, RJ, Russo, P, Haas, N, Doehn, C, Donskov, F, Gross-Goupil, M, Varlamov, S, Kopyltsov, E, Lee, JL, Lim, HY, Melichar, B, Zemanova, M, Rini, B, Choueiri, TK, Wood, L, Reaume, MN, Stenzl, A, Chowdhury, S, McDermott, R, Michael, A, Izquierdo, M, Aimone, P, Zhang, H & Sternberg, CN 2021, 'Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial', European Urology, vol. 79, no. 3, pp. 334-338. https://doi.org/10.1016/j.eururo.2020.12.029

@article{62f006883f374a06925f39e0e92163af,

title = "Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial",

keywords = "Pazopanib, Renal cell carcinoma, Tyrosine kinase inhibitor",

author = "Motzer, {Robert J.} and Paul Russo and Naomi Haas and Christian Doehn and Frede Donskov and Marine Gross-Goupil and Sergei Varlamov and Evgeny Kopyltsov and Lee, {Jae Lyun} and Lim, {Ho Yeong} and Bohuslav Melichar and Milada Zemanova and Brian Rini and Choueiri, {Toni K.} and Lori Wood and Reaume, {M. Neil} and Arnulf Stenzl and Simon Chowdhury and Ray McDermott and Agnieszka Michael and Miguel Izquierdo and Paola Aimone and Hong Zhang and Sternberg, {Cora N.}",

note = "Publisher Copyright: {\textcopyright} 2020 European Association of Urology",

year = "2021",

month = mar,

doi = "10.1016/j.eururo.2020.12.029",

language = "English",

volume = "79",

pages = "334--338",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma

T2 - Final Overall Survival Analysis of the Phase 3 PROTECT Trial

AU - Motzer, Robert J.

AU - Russo, Paul

AU - Haas, Naomi

AU - Doehn, Christian

AU - Donskov, Frede

AU - Gross-Goupil, Marine

AU - Varlamov, Sergei

AU - Kopyltsov, Evgeny

AU - Lee, Jae Lyun

AU - Lim, Ho Yeong

AU - Melichar, Bohuslav

AU - Zemanova, Milada

AU - Rini, Brian

AU - Choueiri, Toni K.

AU - Wood, Lori

AU - Reaume, M. Neil

AU - Stenzl, Arnulf

AU - Chowdhury, Simon

AU - McDermott, Ray

AU - Michael, Agnieszka

AU - Izquierdo, Miguel

AU - Aimone, Paola

AU - Zhang, Hong

AU - Sternberg, Cora N.

PY - 2021/3

Y1 - 2021/3

KW - Pazopanib

KW - Renal cell carcinoma

KW - Tyrosine kinase inhibitor

UR - http://www.scopus.com/inward/record.url?scp=85099463854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85099463854&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2020.12.029

DO - 10.1016/j.eururo.2020.12.029

M3 - Article

C2 - 33461782

AN - SCOPUS:85099463854

SN - 0302-2838

VL - 79

SP - 334

EP - 338

JO - European Urology

JF - European Urology

IS - 3

ER -

Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Fingerprint

Cite this